Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies. This aim is achieved by evaluating the achievement of PASI 50 and PASI 75 scores at week 16 from the start of treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Psoriasis |
| ||
| Psoriatic arthritis |
| ||
| Atopic dermatitis |
| ||
| Chronic urticaria |
| ||
| Suppurative hydrosadenitis |
| ||
| Systemic lupus erythematosus |
| ||
| Acne vulgaris |
| ||
| Rosacea |
| ||
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Questionnaires | Other | This is a collection of data from normal clinical routine: patients will be asked to record the assessments they undergo during their course of treatment, without changing clinical practice in any way. Data inherent to the following procedures will be collected: examinations, laboratory tests, imaging tests, questionnaires and rating scales. |
| Measure | Description | Time Frame |
|---|---|---|
| Registry of ImmuNe-mediated inflammatory Diseases (IMIDs) | Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies. | 15 years |
| Measure | Description | Time Frame |
|---|---|---|
| PASI 50 | Assess attainment of PASI 50 score from the start of treatment to all follow-ups | 15 years |
| PASI 75 | Assess attainment of PASI 75 score from the start of treatment to all follow-ups |
| Measure | Description | Time Frame |
|---|---|---|
| Special populations | Quantification and monitoring of IMID patients belonging to "special populations". Special populations include: homeless, transgender, amputees, para and quadriplegics. | 15 years |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
In this study (registry) will be included all IMID patients afferent to the UO of Dermatology of IRCCS Istituto Ortopedico Galeazzi for an estimated total of 5 years of recruitment.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Giovanni Damiani, Dr. | Contact | 393929403679 | dr.giovanni.damiani@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Giovanni Damiani, Dr. | IRCSS Ortopedico Galeazzi | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| IRCCS Istituto Ortopedico Galeazzi | Milan | 20161 | Italy |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011795 | Surveys and Questionnaires |
| D006403 | Hematologic Tests |
| ID | Term |
|---|---|
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D017531 | Health Care Evaluation Mechanisms |
Not provided
Not provided
Not provided
Not provided
Not provided
| Seborrheic dermatitis |
|
| Contact dermatitis |
|
| Chronic eczema of the hands |
|
| Vitiligo |
|
|
|
| 15 years |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |